“…After the exclusion of duplicates, 87 (SE) and 28 (CS) studies remained and entered stage 2 screening. Of these, 38 clinical studies 2,3,37‐40,43‐74 (SE; dogs, n = 36; cats, n = 5) and 12 clinical studies 37,40,48,49,57,64,75‐80 (CS; dogs, n = 12; cats, n = 0) as well as 37 pharmacokinetic studies 49,57,65,81‐114 (dogs, n = 33; cats, n = 4) fulfilled stage 2 criteria and were selected for review. Some clinical studies included a mixed populations of dogs and cats.…”